AI assistant
Medistim — Earnings Release 2018
Feb 27, 2019
3662_rns_2019-02-27_6eaad698-a828-410c-8c6a-19ac5d422558.html
Earnings Release
Open in viewerOpens in your device viewer
Results for fourth quarter and preliminary results for Medistim for 2018
Results for fourth quarter and preliminary results for Medistim for 2018
It was a sales record for both a quarter and for a year. Sales for the quarter ended at MNOK 97.0 (MNOK 82.2), a 19.1 % growth. Sales for 2018 ended at MNOK 325.9 (MNOK 301.5), a growth of 8.1 %. Currency neutral sales of own products increased with 25.5 % for the quarter. For 2018, currency neutral growth in sales of own products was 10.0%. EBIT for the quarter ended at MNOK 27.8 (MNOK 16.4), a 69.6 % growth. For 2018, EBIT ended at MNOK 74.0 (MNOK 65.5) a 13.0 % growth. USA drives growth and there was a record quarter in the US with a 43.4 % sales growth. Currency neutral growth for the year was 10 %. There was also a solid growth in sales in Asia with 144 % for the quarter and 43 % for the year. Earnings per share ended at NOK 3.14 (NOK 2.62) a 19.8 % increase. The Board suggests a dividend of NOK 2.25 per share (NOK 2.00), a 12.5 % increase.